Home » Topics » Regulatory » Patents

Patents
RSS

AbbVie patents V1bR ligands

Dec. 1, 2015

Italian and U.S. academic team patents ASAH1 inhibitors

Dec. 1, 2015

Novartis discloses TLR7 agonists

Nov. 30, 2015

Bayer Schering Pharma divulges sGC activators

Nov. 30, 2015

Array BioPharma patents Trk-A inhibitor

Nov. 30, 2015

X-Rx reports autotaxin inhibitors

Nov. 30, 2015

AbbVie announces V1bR ligands

Nov. 30, 2015

Peloton Therapeutics disclosed ACSS2 inhibitors

Nov. 30, 2015

University of Colorado patents HDAC/TTK inhibitors

Nov. 30, 2015

Bayer Schering Pharma divulges sGC activators

Nov. 27, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...